← Evidence map

ArticleMolecular cancer2025

Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment.

Kin Man Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40533745